DER SPIEGEL
Suche öffnen
BioNTech CEO Confirms âEncouragingâ Study
Vaccine Could Be Approved for Older Children By Summer
If all goes well, the BioNTech-Pfizer vaccine for COVID-19 could be approved for ages 12 and older by June, and for kids above the age of six months by the fall. But the development would raise new moral and practical questions.
Bild vergröÃern
Children on their way to school: It as right and necessary that children are immunized against COVID-19.
Foto:
Gregor Fischer / dpa
Once a week, the calendar of the approximately 40 executives at BioNTech, the research firm located in the southwestern German city of Mainz, includes a 90-minute appointment that cannot be rescheduled. At the BNT162b2 meeting, all vaccine-related divisions must present what they are currently working on to the board. They explain if the expansion of production is proceeding quickly, for example, or which approaches against the new mutants are being discussed.
COVID-19: Der lange Weg des Impfstoffs msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.